Jan 8 (Reuters) - Standard BioTools Inc LAB.O :
* STANDARD BIOTOOLS ANNOUNCES PRELIMINARY FOURTH QUARTER AND
FULL
YEAR 2023 REVENUE
* STANDARD BIOTOOLS INC: EXPECTS Q4 2023 REVENUE OF
APPROXIMATELY
$28 MILLION
* STANDARD BIOTOOLS INC: SOMALOGIC EXPECTS Q4 2023 REVENUE
OF
APPROXIMATELY $23 MILLION
* STANDARD BIOTOOLS INC: EXPECTS CASH, CASH EQUIVALENTS AND
SHORT-TERM INVESTMENTS OF COMBINED COMPANY TO BE OVER $550
MILLION AS OF DEC 31, 2023
Source text for Eikon: ID:nGNX1Sjsd4
Further company coverage: LAB.O
((Reuters.Briefs@thomsonreuters.com;))